MILabs announces the first installation in Poland of its pre-clinical Adaptive microCT scanner

The Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology (FBBB) at the Jagiellonian University in Kraków recently became the first institute in Poland to install MILabs’ Adaptive U-CT for in-vivo preclinical imaging.

To accommodate the diverse in-vivo imaging needs of the FBBB, including imaging of bones and ossicles plus soft tissues in mice and larger rodents, the university decided to acquire Milabs unique Adaptive CT, a system that can adapt to researchers’ applications so that users don’t have to adapt their research.

Explaining his facility’s decision to select the Adaptive U-CT/XUHR, prof. dr hab. Jan Potempa – Head of Microbiology Department, FBBB at the Jagiellonian University, said, ”We were looking for a single versatile microCT to handle the wide variety of research needs of our Faculty consisting of 17 Departments and Laboratories, while being able to provide high-quality images to meet their specific needs”.

Prof. F. Beekman, CEO/CSO of MILabs: “We are pleased that the most preeminent university of Poland has decided to select our Adaptive U-CT system for its core imaging research. Thanks to our radiation dose efficient design, our microCT is indeed able to handle the most demanding preclinical in-vivo X-ray imaging applications.

 

About FBBB at the Jagiellonian University

The Faculty of Biochemistry, Biophysics and Biotechnology is one of the fifteen faculties of the Jagiellonian University. FBBB is a leading research institution in Poland, well recognized internationally in the field of modern biology. Many scientists from all over the world visit the Faculty each year giving lectures and participating in joint research programs. According to the Nature Index (May 2016), that tracks the affiliations of original research articles, the Faculty received the highest score among all life science research institutions in Poland.

About MILabs B.V.

The company has a history of providing a continuum of innovations to expand the applications of its multimodality imaging solutions used for the development of new diagnostic solutions and therapies for diseases such as diabetes, cancer, cardiac, bone and neurodegenerative diseases.  With its latest adaptive preclinical platform, MILabs has succeeded at commercializing a scalable imaging platform, able to accommodate PET, SPECT, Optical and CT imaging in a single system. Awarded the Commercial Innovation of the Year 2018 at the Molecular Imaging Congress, this platform, whether used as a single modality or multimodality system,  is globally recognized for being able to deliver the highest quality molecular, functional and anatomical images. For more information, visit  www.milabs.com or contact MILabs at [email protected]

About WITKO

Our mission is delivering the innovative solutions for Polish scientists, including: animal imaging (luminescence, fluorescence, PET, SPECT, microCT), isolated organ perfusion, animal handling and breeding, molecular biology, cell biology, biotechnology.

WITKO is the strong complex laboratory supplier (shareholder of the Lab Logistics Group) for universities, pharma, inspections, regulators, and industrial laboratories providing: design of laboratories, delivery and installation of furniture, supply of devices, usables, reagents, performing instruments qualification, and warranty and post warranty service. Our strength and professionalism has been recognized by various awards from scientists’ associations, government authorities, suppliers and Customers.

More information on www.witko.com.pl

Share on social media

Beckman Institute welcomes new ultra-high-performance PET-CT scanner

Beckman Institute at the University of Illinois, Urbana-Champaign Improves Previous Imaging Functionality with Launch of ...
Read More →

Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands – Prof. Harrie Weinans & Dr. Bart van der Wal

  – Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands –  – Prof. ...
Read More →

Press Release: MILABS launches its 7th generation of preclinical imagers at the World Molecular Imaging Conference 2021

Under the new ownership of the Rigaku Group (Tokyo, Japan), MILabs is pushing the value ...
Read More →

Press Release: RIGAKU Acquires Life Science Imaging Equipment Manufacturer MILabs

August 3, 2021 – Houten, the Netherlands Dear readers, We are very excited that MILabs ...
Read More →

Press Release: Confocal PET Causes Spectral PET Breakthrough in Preclinical Imaging

Houten, the Netherlands – March 24, 2021 Using its unique Confocal PET technology, MILabs B.V ...
Read More →

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University – Bridging the “valley of death” ...
Read More →

Spotlight on Bart Cornelissen, PhD – Department of Oncology, Oxford Institute for Radiation Oncology at University of Oxford

– Targeting Tumors from the inside –   Dr. Bart Cornelissen is Group Leader and ...
Read More →

Spotlight on Prof. Twan Lammers – ExMI-RWTH Aachen

A Pioneering Mind in Nanomedicine and Theranostics Prof. Dr. Dr. Twan Lammers is Head of ...
Read More →

Miltenyi Biotec strengthens its research capabilities for cell analysis and preclinical imaging by acquiring a MILabs’ premium Optical/CT imaging system

  Utrecht and Bergisch Gladbach, September 9, 2020 Miltenyi Biotec B.V. & Co. KG, a ...
Read More →

MILabs announced the co-winners of the 2020 MILabs Image of the Year Award

September 4, 2020, Utrecht, The Netherlands Each year, at the occasion of the Annual Congress ...
Read More →

Bayer AS installs top-of-the-line MILabs VECTor PET/SPECT/CT to advance its targeted alpha therapy programs

August 27, 2020, Oslo-Norway and Utrecht-The Netherlands Bayer AS has installed a state-of-the-art MILabs VECTor ...
Read More →

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam On the frontline of fighting ...
Read More →
Scroll to Top